BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 1
• 2
• 3
• 6
• 7
• 8
• 9
• 10
• 13
• 14
• 15
• 16
• 17
• 20
• 21
• 22
• 23
• 24
• 27
• 28
• 29
• 30
• 31

• Biotech Bay

  How Bay Area’s Invitae’s Sales Could Double in 2017

  March 20, 2017

   · 

  1 min read
• Policy

  Cellceutix Takes on Anonymous Blogger, Calls Mako Research’s Actions “Criminal”

  March 20, 2017

   · 

  1 min read
• Drug Development

  This Cheap Michigan Biotech Could Have Major Phase II Catalysts Coming

  March 20, 2017

   · 

  1 min read
• 

  Drug Development

  Intellia’s CEO Has Cambridge-Based Company Moving Forward on Positive in vivo Data

  March 20, 2017

   · 

  4 min read
• BioCapital

  Is This New Device The Future Of The Workplace?

  March 20, 2017

   · 

  1 min read
• 

  Business

  Questions Arise Over This Bay Area Biotech CEO’s Doctorate Degree and His Time at the University of Pennsylvania

  March 20, 2017

   · 

  3 min read
• 

  Job Trends

  Cerulean to Slash More Than Half of Its Remaining Staff, Merge With SoCal Biotech

  March 20, 2017

   · 

  2 min read
• 

  Ex-GlaxoSmithKline Scientists’ Pulmocide Hauls in $30.4 Million

  March 20, 2017

   · 

  3 min read
• 

  Drug Development

  Investors Squeal With Delight as Eli Lilly’s Breast Cancer Combo Succeeds in Phase III, Faces Tough Competition from Pfizer and Novartis AG

  March 20, 2017

   · 

  3 min read
• EKF diagnostic GmbH Ponders Over Splitting Company in Two

  March 20, 2017

   · 

  1 min read